WednesdayMay 13, 2026 10:30 am

Greenland Energy Company (NASDAQ: GLND) Advances Greenland Oil Strategy with Major Drilling Agreements

Greenland’s recent agreements secures access to advanced rig capacity, operational support intended to facilitate future drilling activity. Greenland now possess the best-in-class logistics and operational infrastructure, among the largest challenges facing Arctic exploration. The Jameson Land Basin, where Greenland Energy is drilling, has attracted attention because it may contain significant undiscovered hydrocarbon resources. As global energy markets continue searching for long-term supply security outside traditional producing regions, Greenland is emerging as a frontier attracting renewed attention from explorers and investors alike. Greenland (NASDAQ: GLND), a recently formed energy exploration company focused on Greenland’s hydrocarbon potential, has taken a key step…

Continue Reading

WednesdayMay 13, 2026 9:45 am

Numa Numa Resources Inc. Reimagines Panguna as Mining Shifts from Conflict to Cooperation

Mining projects have often been catalysts for both economic growth and social tension, particularly in regions where governance structures were still evolving. The Panguna Mine in Bougainville stands as one of the most prominent examples of this dynamic. Numa Numa Resources is positioning itself as part of a new chapter in Bougainville’s mining story. Disseminated on behalf of Numa Numa Resources Inc. and may include paid advertisements. Across the world, some of the most valuable mineral deposits sit idle not because they are depleted, but because political change—and ultimately history—left them behind. In Bougainville, Numa Numa Resources is part of…

Continue Reading

WednesdayMay 13, 2026 9:35 am

QualityStocksNewsBreaks – SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Featured in BioMedWire Editorial on Next-Generation GLP-1 Innovation

This article has been disseminated on behalf of SureNano Science Ltd. and may include paid advertising. SureNano Science (CSE: SURE) (OTCQB: SURNF) was featured in BioMedWire editorial coverage examining the rapid growth of the GLP-1 market, with the company highlighted for its subsidiary GlucaPharm Inc. and its development of GEP-44, a patented triple agonist peptide licensed from Syracuse University. The editorial notes that GEP-44 is designed to target GLP-1 and peptide YY receptors Y1 and Y2, positioning SureNano as an emerging microcap participant seeking to address limitations of first-generation GLP-1 therapies, including efficacy, tolerability and delivery flexibility. The coverage also…

Continue Reading

WednesdayMay 13, 2026 9:20 am

QualityStocksNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in BioMedWire Editorial on Next-Generation CNS Drug Delivery

Oncotelic Therapeutics (OTCQB: OTLC) was featured in BioMedWire editorial coverage examining the growing urgency around effective central nervous system drug delivery, with the company highlighted for its proprietary intranasal nose-to-brain delivery platform designed to bypass the blood-brain barrier and deliver therapeutics directly to the brain. The editorial points to rising global Alzheimer’s cases and increased biodefense focus as major catalysts driving demand for faster, more targeted CNS delivery technologies, positioning Oncotelic’s platform-based approach as part of a broader shift toward delivery innovation as a critical determinant of therapeutic success. The coverage also places Oncotelic alongside major biopharma and advanced therapeutics…

Continue Reading

WednesdayMay 13, 2026 9:10 am

QualityStocksNewsBreaks – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) Spotlighted in BioMedWire Editorial on AI-Driven Impairment Detection

This article has been disseminated on behalf of MindBio Therapeutics Corp. and may include paid advertising. MindBio Therapeutics (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) was featured in BioMedWire editorial coverage highlighting the growing demand for real-time, noninvasive impairment detection technologies, with the company positioned as a differentiated player leveraging artificial intelligence and voice analysis to identify intoxication from brief speech recordings. The editorial underscores the limitations of conventional detection tools such as breathalyzers, blood draws and urine testing, noting MindBio’s focus on scalable, real-time assessment across multiple substances for potential applications in workplace safety, law enforcement, healthcare and public health.…

Continue Reading

WednesdayMay 13, 2026 9:00 am

Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) Details Key Milestones and Future Drilling Plans at Emerging Growth Conference

Disseminated on behalf of Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) and may include paid advertising. The company is advancing an uncommon sedimentary phosphate project in northeast Nevada aimed at supplying direct-application organic fertilizer to U.S. agriculture markets. NOP’s unprocessed direct-application phosphate does not have to compete with the conventional chemical agricultural input industry, and has no large scale competition in North America. The project’s phosphate is intended for direct field application without chemical processing, potentially reducing capital requirements compared with conventional phosphate operations. Phosphate has now been added to the U.S. critical minerals list, increasing strategic attention on…

Continue Reading

TuesdayMay 12, 2026 12:15 pm

QualityStocksNewsBreaks – Titan Partners Group LLC Expands Equity Research Division with Three Senior Analyst Appointments

Titan Partners, a division of American Capital Partners, has appointed Scott Buck, Kyle Bauser, Ph.D., and Adam Kelsey, CFA, to significantly expand its equity research platform across technology, healthcare, and energy, power and infrastructure. The three analysts bring more than 40 years of combined middle-market equity research experience, strengthening Titan’s sector-focused research capabilities as the firm continues to build its investment banking platform focused on underfollowed small- and mid-cap public companies. To view the full press release, visit https://ibn.fm/6KxBz About Titan Partners Titan Partners, a division of American Capital Partners, is a boutique investment bank specializing in tailored solutions for…

Continue Reading

TuesdayMay 12, 2026 12:02 pm

QualityStocksNewsBreaks – Nevada Organic Phosphate Inc. (CSE: NOP; OTCQB: NOPFF) Commences 2026 Drilling at Murdock Mountain Project

This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising.  Nevada Organic Phosphate (CSE: NOP; OTCQB: NOPFF) has commenced drilling on the first hole of its 2026 exploration program at the Murdock Mountain Project, with initial deep drill hole MM26-7 designed as a 100-meter step-back from last fall’s MM25-1 to further evaluate the thickness, continuity and phosphate grade characteristics of the Meade Peak Upper Phosphatic Zone at depth. The company said minor technical drilling issues were identified and are being addressed by contractor FTE Drilling, with operations expected to resume shortly and no material delays anticipated. To view the full press release, visit https://ibn.fm/oieTp Nevada Organic…

Continue Reading

TuesdayMay 12, 2026 11:51 am

QualityStocksNewsBreaks – SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Featured in BioMedWire Editorial on Next-Generation GLP-1 Innovation 

This article has been disseminated on behalf of SureNano Science Ltd.  and may include paid advertising.  SureNano Science (CSE: SURE) (OTCQB: SURNF) announced its placement in a BioMedWire editorial examining the evolution of GLP-1 therapies and emerging innovation in obesity and metabolic disease treatment. The editorial highlights SureNano’s subsidiary GlucaPharm Inc. and its GEP-44 program, a novel triple agonist peptide designed to improve efficacy, tolerability and delivery flexibility in the rapidly expanding GLP-1 market, as demand continues to grow for next-generation therapies targeting obesity, type 2 diabetes and related chronic conditions. To view the full press release, visit https://ibn.fm/pzQjm About SureNano Science Ltd. SureNano Science Ltd. (CSE: SURE) is a Canadian life sciences company focused on acquiring, developing, and advancing innovative pharmaceutical…

Continue Reading

TuesdayMay 12, 2026 11:08 am

QualityStocksNewsBreaks – Qdrant Powers Sapu AI Platform Indexing 28 Million PubMed Abstracts to Accelerate Cancer Research 

Qdrant’s vector database infrastructure supports the AI-powered research platform used by SAPU Bioscience, a subsidiary of Oncotelic Therapeutics Inc. (OTCQB: OTLC), enabling large-scale biomedical literature analysis   SAPU’s platform has indexed 28 million PubMed abstracts into a single searchable collection, supporting AI-assisted research workflows and peer-reviewed scientific output  The AI ecosystem aligns with Oncotelic’s broader strategy of integrating artificial intelligence, nanoparticle development and accelerated drug discovery platforms  In a blog post by Daniel Azoulai, Qdrant highlighted how Sapu, an early-stage biopharmaceutical company developing treatments for hard-to-treat cancers, uses Qdrant Cloud infrastructure to power an AI research platform capable of indexing and querying all 28 million PubMed abstracts in a single searchable collection, helping accelerate biomedical…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered